NCT05477953View on ClinicalTrials.gov

An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's Health

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

January 31, 2032

Study Completion Date

January 31, 2032

Conditions
Chagas Disease
Interventions
DRUG

Nifurtimox (BAYA2502)

At least 1 dose of nifurtimox

Trial Locations (10)

26505

Many Locations, Multiple Locations

Unknown

Many Locations, Multiple Locations

Many Locations, Multiple Locations

Many Locations, Multiple Locations

Many Locations, Multiple Locations

Many Locations, Multiple Locations

Many Locations, Multiple Locations

Many locations, Multiple Locations

Many Locations, Multiple Locations

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY